Rochester, MN - A new case series of patients with a previous stroke suggests that transcatheter device closure of patent foramen ovale (PFO) and atrial septal defect (ASD) is safe and eliminated ...
The US Food and Drug Administration (FDA) has approved the Gore Cardioform septal occluder for closure of patent foramen ovale (PFO) to prevent recurrent ischemic stroke, the manufacturer, WL Gore & ...
CHICAGO – Patients who have a heart defect known as patent foramen ovale incidentally discovered and repaired during surgery for a different condition may have an increased odds of postoperative ...
TCT 602: Feasibility and Safety of Same Day Discharge for Patent Forman Ovale Closures Using Intracardiac Echo and Moderate Sedation Receive the the latest news, research, and presentations from major ...
Percutaneous closure can be described as a less-invasive surgical procedure used to treat patients with atrial septal defect (ASD) or patent foramen ovale (PFO). Since the utilization of percutaneous ...
An atrial septal defect is a congenital heart issue. According to the Centers for Disease Control and Prevention (CDC), it develops in about 1 in 1,859 babies in the United States. An atrial septal ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
The association between migraine with aura and persistent foramen ovale (PFO), as well as other right-to-left shunts, is described. A hypothesis that might explain this association is discussed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback